|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 32.98 USD | +4.67% |
|
-2.54% | -6.25% |
| 06.03. | Führende Pharmakonzerne im Wettlauf um die Abnehmpille | RE |
| 12.02. | VIKING THERAPEUTICS, INC. : Morgan Stanley behält die Bewertung Kaufen bei | ZM |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +4.67% | -2.54% | +15.96% | -14.45% | -6.25% | +13.33% | +191.09% | +395.94% | +1’433.95% | 3.81 Mrd. | ||
| -0.61% | -5.35% | -10.55% | -19.30% | -13.20% | +12.03% | +92.93% | +160.33% | +5’982.11% | 44.16 Mrd. | ||
| +0.92% | -4.81% | -4.63% | +3.21% | +2.93% | +49.26% | +14.90% | -17.42% | - | 40.5 Mrd. | ||
| -2.40% | -6.16% | -6.49% | -31.31% | -19.48% | +87.11% | +608.08% | +267.51% | +953.61% | 30.21 Mrd. | ||
| -0.44% | -7.92% | -4.80% | +5.45% | +6.62% | -6.69% | -21.33% | +5.51% | - | 25.47 Mrd. | ||
| +2.54% | -9.65% | -3.56% | +11.40% | +15.59% | +53.01% | -34.70% | -59.40% | - | 19.22 Mrd. | ||
| -2.62% | -6.49% | -11.72% | -14.94% | -14.73% | +4.16% | -31.60% | -9.10% | +110.54% | 16.5 Mrd. | ||
| +5.20% | +0.37% | +6.34% | -13.54% | -5.04% | +47.19% | +154.57% | +126.61% | - | 12.64 Mrd. | ||
| +1.14% | -8.92% | +0.80% | -17.48% | -13.61% | -15.02% | +994.93% | +166.49% | +123.85% | 11.72 Mrd. | ||
| +4.43% | -0.31% | -8.74% | -16.04% | -1.53% | +55.98% | - | - | - | 11.51 Mrd. | ||
| +0.64% | -5.71% | -5.36% | -6.35% | -5.21% | +7.69% | +152.09% | +86.05% | +861.69% | 10.79 Mrd. | ||
| -1.48% | +0.19% | -9.37% | -25.03% | -25.67% | +30.60% | +62.30% | +272.23% | - | 9.93 Mrd. | ||
| -3.03% | -19.41% | -2.51% | +5.63% | -26.78% | - | - | - | - | 9.11 Mrd. | ||
| -3.24% | -11.35% | +43.31% | +278.60% | +337.88% | +189.00% | +402.61% | - | - | 8.91 Mrd. | ||
| +1.79% | -3.97% | +5.59% | +27.56% | +28.50% | -16.70% | +45.11% | +149.54% | - | 8.53 Mrd. | ||
| -5.94% | -5.45% | -7.28% | -2.64% | -9.90% | +252.50% | +96.13% | -13.30% | +1’156.72% | 8.38 Mrd. | ||
| +0.74% | -.--% | -.--% | -.--% | -.--% | -.--% | +66.95% | +226.27% | - | 8.19 Mrd. | ||
| +1.31% | -3.59% | -3.46% | +36.06% | +48.51% | +34.01% | +58.73% | +534.91% | +370.56% | 8.14 Mrd. | ||
| -0.72% | -2.49% | -4.04% | -9.30% | -1.17% | +39.88% | +238.13% | - | - | 7.82 Mrd. | ||
| +10.92% | +5.90% | +8.39% | -3.45% | +18.47% | +379.21% | +64.51% | -10.35% | - | 7.65 Mrd. | ||
| Durchschnitt | +0.69% | -4.55% | -0.11% | +9.71% | +15.80% | +64.03% | +175.30% | +142.61% | +1’374.13% | 15.16 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +0.25% | -4.92% | -3.23% | +1.49% | +6.77% | +50.07% | +163.15% | +110.17% | +2’421.41% |
- Börse
- Aktien
- A12GD6 Aktie
- Sektor Viking Therapeutics, Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben
















